These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 23868181)

  • 1. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
    Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.
    Sung WW; Chu YC; Chen PR; Liao MH; Lee JW
    Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
    Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
    Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.
    Li YY; Chung GT; Lui VW; To KF; Ma BB; Chow C; Woo JK; Yip KY; Seo J; Hui EP; Mak MK; Rusan M; Chau NG; Or YY; Law MH; Law PP; Liu ZW; Ngan HL; Hau PM; Verhoeft KR; Poon PH; Yoo SK; Shin JY; Lee SD; Lun SW; Jia L; Chan AW; Chan JY; Lai PB; Fung CY; Hung ST; Wang L; Chang AM; Chiosea SI; Hedberg ML; Tsao SW; van Hasselt AC; Chan AT; Grandis JR; Hammerman PS; Lo KW
    Nat Commun; 2017 Jan; 8():14121. PubMed ID: 28098136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
    Thornburg NJ; Pathmanathan R; Raab-Traub N
    Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
    Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
    Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.
    Man CH; Wei-Man Lun S; Wai-Ying Hui J; To KF; Choy KW; Wing-Hung Chan A; Chow C; Tin-Yun Chung G; Tsao SW; Tak-Chun Yip T; Busson P; Lo KW
    J Pathol; 2012 Feb; 226(3):471-81. PubMed ID: 22009689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
    J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.
    Chen CC; Liu HP; Chao M; Liang Y; Tsang NM; Huang HY; Wu CC; Chang YS
    Oncogene; 2014 Jul; 33(28):3648-59. PubMed ID: 23975427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation.
    Lui VW; Yau DM; Cheung CS; Wong SC; Chan AK; Zhou Q; Wong EY; Lau CP; Lam EK; Hui EP; Hong B; Hui CW; Chan AS; Ng PK; Ng YK; Lo KW; Tsang CM; Tsui SK; Tsao SW; Chan AT
    Oncogene; 2011 Mar; 30(13):1518-30. PubMed ID: 21119603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
    J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis?
    Yi M; Cai J; Li J; Chen S; Zeng Z; Peng Q; Ban Y; Zhou Y; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Aug; 233(8):5537-5549. PubMed ID: 29266238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
    Thornburg NJ; Raab-Traub N
    J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma.
    Li Z; Duan Y; Cheng S; Chen Y; Hu Y; Zhang L; He J; Liao Q; Yang L; Sun LQ
    Oncotarget; 2015 Sep; 6(27):24291-303. PubMed ID: 26172457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.
    Chiu SH; Wu CC; Fang CY; Yu SL; Hsu HY; Chow YH; Chen JY
    Oncotarget; 2014 Sep; 5(18):8583-601. PubMed ID: 25261366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells.
    Mei YP; Zhou JM; Wang Y; Huang H; Deng R; Feng GK; Zeng YX; Zhu XF
    Cell Cycle; 2007 Jun; 6(11):1379-85. PubMed ID: 17507800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape.
    Bruce JP; To KF; Lui VWY; Chung GTY; Chan YY; Tsang CM; Yip KY; Ma BBY; Woo JKS; Hui EP; Mak MKF; Lee SD; Chow C; Velapasamy S; Or YYY; Siu PK; El Ghamrasni S; Prokopec S; Wu M; Kwan JSH; Liu Y; Chan JYK; van Hasselt CA; Young LS; Dawson CW; Paterson IC; Yap LF; Tsao SW; Liu FF; Chan ATC; Pugh TJ; Lo KW
    Nat Commun; 2021 Jul; 12(1):4193. PubMed ID: 34234122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.